GTC-3000

N/A

Report date: 2025/06/11 11:16:48
NME

Base Information

Drug NameGTC-3000
Drug Alias Nameglycosaminoglycan interacting small molecules (Gismo Therapeutics)GISMO (Gismo Therapeutics)GTC-3034GTC-4012GTC-3000 +[6] 
ClassificationSmall molecules
Mechanisms of ActionGlycosaminoglycan modulatorsBeta amyloid A4 protein modulatorsNeuroprotectants
TargetsBeta amyloid A4 proteinGlycosaminoglycan
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGismo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGismo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A